AbbVie
AbbVie

Dividends • AbbVie

ABBV

AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics (including Botox).

See below the complete and updated table with all dividends paid and declared history, etc

Excluding Date
Payment
Value ($)
Frequency
4/15/2025
5/15/2025
1,64
Quarterly
1/15/2025
2/14/2025
1,64
Quarterly
10/15/2024
11/15/2024
1,55
Quarterly
7/15/2024
8/15/2024
1,55
Quarterly
4/12/2024
5/15/2024
1,55
Quarterly
1/12/2024
2/15/2024
1,55
Quarterly
10/12/2023
11/15/2023
1,48
Quarterly
7/13/2023
8/15/2023
1,48
Quarterly
4/13/2023
5/15/2023
1,48
Quarterly
1/12/2023
2/15/2023
1,48
Quarterly
10/13/2022
11/15/2022
1,41
Quarterly
7/14/2022
8/15/2022
1,41
Quarterly
4/13/2022
5/16/2022
1,41
Quarterly
1/13/2022
2/15/2022
1,41
Quarterly
10/14/2021
11/15/2021
1,3
Quarterly
7/14/2021
8/16/2021
1,3
Quarterly
1/4